Issue 45, 2017, Issue in Progress

The significance of a new parameter – plasma protein binding – in therapeutic drug monitoring and its application to carbamazepine in epileptic patients

Abstract

Free drug concentration (Cf) is instantaneous and susceptible to sampling time, which can confuse clinicians and cause them to adjust the dosage regimen. In the present work, we indicated a new parameter, the plasma protein binding (PPB) of clinical plasma samples, and discussed its application in TDM (Therapeutic Drug Monitoring). Furthermore, carbamazepine was selected as a model drug to develop a simple pretreatment method for the determination of PPB, in which Cf and Ct can be simultaneously analyzed in one plasma sample using a single device. Our results demonstrated that this proposed method exhibited some advantages, including perfect recovery (approximately 100%) and high precision (CV% < 3.0%). Furthermore, it achieved successful application in real plasma samples. Individual differences in PPB (from 10.1–68.9%) were among patients, and in additon, between the patients and healthy people (p < 0.05). Moreover, there was a weak correlation between Ct and Cf (r2 = 0.470 and p < 0.05), so the Cf of CBZ cannot be estimated from Ct. However, the primary cause of the variability of Cf is the change in PPB. As a consequence, applying PPB to guide individual dose adjustment is more accurate and more scientific than using Cf or Ct.

Graphical abstract: The significance of a new parameter – plasma protein binding – in therapeutic drug monitoring and its application to carbamazepine in epileptic patients

Article information

Article type
Paper
Submitted
13 Mar 2017
Accepted
04 May 2017
First published
26 May 2017
This article is Open Access
Creative Commons BY-NC license

RSC Adv., 2017,7, 28048-28055

The significance of a new parameter – plasma protein binding – in therapeutic drug monitoring and its application to carbamazepine in epileptic patients

J. Gao, X. Wang, J. An, C. Du, M. Li, H. Ma, L. Zhang, J. Bian and Y. Jiang, RSC Adv., 2017, 7, 28048 DOI: 10.1039/C7RA02991H

This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. You can use material from this article in other publications, without requesting further permission from the RSC, provided that the correct acknowledgement is given and it is not used for commercial purposes.

To request permission to reproduce material from this article in a commercial publication, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party commercial publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements